Cargando...
Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Alzheimer’s disease (AD) affects an estimated 44 million individuals worldwide, yet no therapeutic intervention is available to stop the progression of the dementia. Neuropathological hallmarks of AD are extracellular deposits of amyloid beta (Aβ) peptides into plaques, intraneuronal accumulation of...
Guardado en:
| Publicado en: | Curr Alzheimer Res |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5328927/ https://ncbi.nlm.nih.gov/pubmed/27697064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1567205013666160930110551 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|